News
![Homeless person during COVID-19 pandemic](https://isi.utoronto.ca/wp-content/uploads/2020/09/COVID-Homeless.png)
Critical Perspectives on Homelessness and COVID-19
On August 11, the Affordable Housing Challenge Project held our first online seminar since the arrival of the pandemic, Critical Perspectives on Homelessness and COVID-19. We were joined by guests Dawnmarie Harriott (coordinator of Voices from the Street at Working for Change) and Emily Paradis (affordable housing advocate, activist and instructor with the University of Toronto’s […]
![](https://isi.utoronto.ca/wp-content/uploads/2020/08/lost-art-1024x512.png)
'Lost art: Measuring COVID-19’s devastating impact on America’s creative economy' - A Report by Richard Florida, via Brookings.
"This study estimates the effects of the COVID-19 crisis on the creative economy, which is comprised of industries such as film, advertising, and fashion as well as creative occupations such as musicians, artists, performers, and designers. We estimate losses in sales of goods and services, employment, and earnings for creative industries and creative occupations at […]
![Poster of a Medicine by Design event](https://isi.utoronto.ca/wp-content/uploads/2020/09/20190624_073919-800x600-1.jpg)
Critical planning for regenerative medicine therapies needs to happen now to ensure smooth adoption into health system
Article from: https://mbd.utoronto.ca/news/critical-planning-for-regenerative-medicine-therapies-needs-to-happen-now-to-ensure-smooth-adoption-into-health-system-paper-urges/ Regenerative medicine holds the potential to revolutionize health care, but critical work needs to be done now to ensure these new therapies will be safe, effective, affordable, and widely available to patients who need them. That is one of the key conclusions of a paper published online today in Cell & Gene Therapy Insights that […]
![Graphic banner with red and blue bubbles stating 2020 Grand Questions Program, apply by August 21, 2020.](https://isi.utoronto.ca/wp-content/uploads/2020/07/2020-Grand-Questions-Program-Hmpg-Header-1536x667-1-1024x445.jpg)
Medicine by Design’s Grand Questions Program aims to revolutionize regenerative medicine
See story here: https://mbd.utoronto.ca/news/medicine-by-designs-grand-questions-program-aims-to-revolutionize-regenerative-medicine/ By Julie Crljen|July 15th, 2020|Categories: Grand Questions, News|Tags: awards, Grand Questions, innovation Can we make human cells and tissues that perform better than nature? Can we reverse aging and make old cells young again? And how can we ensure regenerative medicine is available and affordable to everyone? These are some of […]
![Dr. Kristin Cleverley headshot](https://isi.utoronto.ca/wp-content/uploads/2020/07/Cleverley_News-490x250-1.jpg)
Dr. Kristin Cleverley awarded Institutional Strategic Initiatives funding for “Mental Health for Students and Youth” research
Article from: https://bloomberg.nursing.utoronto.ca/uncategorized/dr-kristin-cleverley-awarded-institutional-strategic-initiatives-funding-for-mental-health-for-students-and-youth-research/ Dr. Kristin Cleverley has been awarded one year of Institutional Strategic Initiatives (ISI) funding from the University of Toronto (U of T) to develop an ISI Development & Launch proposal for a research initiative on “Mental Health for Students and Youth”. This initiative will establish a unique network focused on research excellence […]
![Image of Medicine by Design Symposium podium](https://isi.utoronto.ca/wp-content/uploads/2020/06/MBD-Symposium-full-87-720x480-1.jpg)
Medicine by Design launches Translation Talks
Article from https://mbd.utoronto.ca/news By Ann Perry|June 16th, 2020|Categories: News|Tags: commercialization, events, Summer by Design, Translation Talks Translation Talks is a weekly webinar series for trainees that will cover key concepts in translation and commercialization of regenerative medicine. (Photo by Neil Ta) Translating research discoveries into new products, therapies or companies isn’t something most graduate programs […]
![PRiME (Next Generation Precision Medicine) logo](https://isi.utoronto.ca/wp-content/uploads/2020/06/preim2.jpg)
Start-ups founded by PRiME members attract major pharmaceutical partners and acquirers
Article from https://www.prime.utoronto.ca/news Start-up companies co-founded by PRiME faculty members, Sachdev Sidhu and Jason Moffat, have garnered the attention of major pharmaceutical partners, with several acquisitions transpiring over the last month. Earlier this week, Gilead Sciences purchased a stake in Pionyr Immunotherapeutics for $275M to access its Myeloid TuningTM approach to cancer immunotherapies. The technology, […]
![Digital illustration of a virus](https://isi.utoronto.ca/wp-content/uploads/2020/06/AdobeStock_virus.jpg)
PRiME announces a COVID-19 Task Force on Advanced Diagnostics and New Therapeutics
Article from https://www.prime.utoronto.ca/news As the global community responds to the COVID-19 pandemic, PRiME is convening its leading researchers to form a COVID-19 Task Force on Advanced Diagnostics and New Therapeutics to develop an arsenal of breakthroughs to fight COVID-19 and future pandemics. UofT researchers who are leading experts in disease biology, medicinal chemistry, device engineering, […]
![Mitochondrial Innovation Initiative (MITO2i) logo](https://isi.utoronto.ca/wp-content/uploads/2020/06/MITO2i_Colour-Wordmark_Digital-2.png)
MITO2i launched as Institutional Strategic Initiative
What MITO2i does: DEVELOPING AWARENESS, ALIGNMENT AND INTEGRATION IN MITOCHONDRIALHEALTH AND DISEASE The relationship between mitochondrial dysfunction and severe mitochondrial disease has long been known. More recent research has established links to a broad range of neurodegenerative and metabolic disorders. This is a game-changer. Unveiling how mitochondrial dysfunction is implicated in multiple diseases will transform medical diagnoses, technologies […]
![Padlock over a world map superimposed with ones and zeroes](https://isi.utoronto.ca/wp-content/uploads/2020/06/Screenshot_2020-06-25-Edit-Post-%E2%80%B9-Institutional-Strategic-Initiatives-%E2%80%94-WordPress.png)
What are regulatory markets and how can they help ensure that AI is safe, fair, and ethical?
Article from https://sr-institute.utoronto.ca/openai/ Misinformation and election interference. Racial bias in the criminal justice system. Self-driving car accidents. Artificial intelligence is changing the world so quickly, it’s unclear how regulators can keep up with ongoing developments. As the COVID-19 pandemic continues to affect our communities and the world, the need for nimble and responsive AI regulation […]
![Photo of Shaf Keshavjee from Medicine by Design](https://isi.utoronto.ca/wp-content/uploads/2020/06/Shaf-Keshavjee.jpg)
Medicine by Design announces four new team projects
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects that will lead to advances in the understanding and treatment of cardiovascular and lung diseases, diabetes and neurological disorders.
![Professors from Prime (From left to right: Kelley, Laflamme, and Miller)](https://isi.utoronto.ca/wp-content/uploads/2020/06/Kelley-Laflamme-Miller.jpg)
Medicine by Design to accelerate regenerative medicine discovery and translation with new $20-million investment
Article from https://mbd.utoronto.ca/news/team-project-awards-cycle-2/ By AnnBy Ann Perry and Jovana Drinjakovic University Professor Shana Kelley (left) at the Leslie Dan Faculty of Pharmacy, Dr. Michael Laflamme (centre), a senior scientist at the McEwen Stem Cell Institute at University Health Network, and Freda Miller, a senior scientist at The Hospital for Sick Children, are leading three of […]